Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid

Kittipan Rerkasem1, Patrick J Gallagher, Robert F Grimble

  • 1Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. krerkase@mail.med.cmu.ac.th

Insights

Management of high cholesterol in patients undergoing carotid endarterectomy (CEA) is inadequate. Many patients awaiting CEA have uncontrolled hypercholesterolemia, indicating a need for better lipid management strategies.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Lipidology

Background:

  • Hypercholesterolemia is a significant risk factor in carotid atherosclerosis.
  • Effective management of lipid risk factors is crucial for patients with carotid stenosis.
  • Limited research exists on the attention given to lipid management in patients awaiting carotid endarterectomy (CEA).

Purpose of the Study:

  • To evaluate the management of hypercholesterolemia in patients scheduled for CEA.
  • To assess patient awareness of their hypercholesterolemia status.
  • To examine the relationship between cholesterol levels and carotid plaque morphology.

Main Methods:

  • Prospective study of 141 consecutive patients undergoing elective CEA.
  • Collection of patient medical history and plasma cholesterol levels.
  • Histological scoring of carotid plaques using established criteria.

Main Results:

  • 28.6% of treated hypercholesterolemic patients awaiting CEA had cholesterol levels >= 5 mmol/L.
  • 32.5% of patients informed they had no hypercholesterolemia had cholesterol levels >= 5 mmol/L.
  • 48.4% of patients with unmeasured cholesterol had levels >= 5 mmol/L, with a tendency towards more severe plaque pathology.

Conclusions:

  • Hypercholesterolemia appears to be poorly managed in the population of patients awaiting CEA.
  • There is a significant gap in lipid management and patient awareness for this high-risk group.
  • Improved strategies for cholesterol management are warranted for patients with carotid stenosis.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...